Article: Availability of additional trivalent inactivated influenza vaccine for adults (Afluria[R]).(Notice to Readers)(Brief article)

On September 28, 2007, CSL Biotherapies, Inc., (King of Prussia, Pennsylvania) received approval from the Food and Drug Administration for use of Afluria[R], a trivalent inactivated influenza vaccine (TIV) administered intramuscularly in persons aged [greater than or equal to] 18 years (1). Afluria can be used for any adult influenza vaccine indication (2).

The addition of Afluria brings to six (five TIVs and one live, attenuated influenza vaccine) the number of seasonal influenza vaccines licensed for the U.S. market. CDC estimates that manufacturers of the six vaccines will supply a record 132 million doses of influenza vaccine for the 2007-08 influenza season.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!